Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SIMPONI
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
- A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®
- A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
- Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis
- Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects
- A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes
- Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels
- NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis
- Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
- Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients
- A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
- Initial Treatment With Golimumab in Early PsA
- A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
- Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
- A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis
- RHYTHM (Formerly Escape II Myocardium)
- Intratympanic Injection for Autoimmune Inner Ear Disease
- A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
- A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects
- A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects
- Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)
Clinical trials list
click for details